Search results
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the...
FOX 59 Indianapolis· 21 hours agoMedivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative...
Calliditas Announces Positive NefIgArd Open Label Extension Results
Morningstar· 2 days agoSTOCKHOLM, April 24, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas ...
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase...
FOX 23 News Albany· 3 days agoMedivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative...
Vicore to Present at Upcoming Investor Conferences
Digital Journal· 2 weeks agoUsing its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company's ...
Senzime publishes annual and sustainability report for 2023
Digital Journal· 2 days agoAbout SenzimeSenzime, headquartered in Sweden, is a leading medical device company that develops, manufactures, and markets CE- and FDA
Recruitment milestone reached in Diamyd® Phase 3 trial
Morningstar· 2 weeks agoSTOCKHOLM, April 12, 2024 /PRNewswire/ -- Diamyd Medical's precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious ...
Senzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System
Digital Journal· 2 days agoThe company provides an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for accurate monitoring of neuromuscular and respiratory ...
